9 terminated. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
| Phase 1 | 1 | Terminated 1 |
Follow Inhalation: new trials by email Literature Review of Inhalation trials Research Report on Inhalation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium Bromide Powder for inhalation - Chronic Obstructive Pulmonary Disease | Phase 2 | Terminated | Jiangsu HengRui Medicine Co., Ltd. | 82 | 2024-01-15 | 2025-12-22 |
| A Phase II Clinical Trial of TQC3721 Suspension for Inhalation TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 59 | 2022-05-20 | 2025-04-20 |
| Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms Drug, inhalation - Covid19 | Phase 2 | Terminated | Aquilon Pharmaceuticals S.A. | 21 | 2021-11-04 | 2023-01-06 |
| A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age Lucinactant for Inhalation, nCPAP Only - Respiratory Distress Syndrome, Newborn | Phase 2 | Terminated | Windtree Therapeutics | 12 | 2020-04-18 | 2023-05-24 |
| Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation - Respiratory Tract Infections, Corona Virus Infection | Phase 2 | Terminated | Chris Miller | 13 | 2017-10-24 | 2021-07-16 |
| Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA Lucinactant for inhalation, nCPAP alone - Respiratory Distress Syndrome | Phase 2 | Terminated | Windtree Therapeutics | 48 | 2015-08-01 | 2019-07-23 |
| Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis Treprostinil sodium for inhalation - Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Terminated | Lung Biotechnology PBC | 1 | 2008-06-01 | 2018-05-11 |
| Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701) INS316 solution for inhalation, hypertonic saline 3% sodium chloride solution - Interstitial Lung Disease | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 22 | 2003-01-01 | 2015-10-29 |
| Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation nitric oxide for inhalation, Oxygen - Lung Disease, Hypoxemia | Phase 1 / Phase 2 | Terminated | Mallinckrodt | 7 | 2002-05-01 | 2016-10-19 |
COVID-19 (2) · Pulmonary Disease, Chronic Obstructive (2) · Respiratory Distress Syndrome (2) · Acidosis, Respiratory (1) · Coronavirus Infections (1) · Hypertension, Pulmonary (1) · Hypoxia (1) · Idiopathic Pulmonary Fibrosis (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Motor Activity (1) · Pulmonary Fibrosis (1) · Respiratory Distress Syndrome, Newborn (1) · Respiratory Tract Infections (1)
Windtree Therapeutics (2) · Aquilon Pharmaceuticals S.A. (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Chris Miller (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Lung Biotechnology PBC (1) · Mallinckrodt (1) · Merck Sharp & Dohme LLC (1)
United States (3) · Canada (2) · China (2) · Poland (2) · Belgium (1) · Chile (1)
Carlos Guardia, MD (1) · Jeremy D Road, MD (1) · Julien Guiot, MD (1) · Steve Simonson, MD (1) · Waldemar Carlo, MD (1)